Jason M. Redman

Hospital Medicine | Oncology

8600 Old Georgetown Rd
Bethesda, MD 20814

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

Journal: Journal for immunotherapy of cancer

Published: July 08, 2026

GZMK expression within activated intratumoral T-cell subsets reflects differentiation efficiency and predicts response to cancer immunotherapy.

GZMK expression within activated intratumoral T-cell subsets reflects differentiation efficiency and predicts response to cancer immunotherapy.

Journal: NPJ precision oncology

Published: December 19, 2025

The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer.

The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer.

Journal: The oncologist

Published: August 26, 2025

Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial.

Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial.

Journal: JAMA oncology

Published: February 20, 2025

PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer.

PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: October 21, 2024

Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection.

Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection.

Journal: The oncologist

Published: September 18, 2024

Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation.

Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation.

Journal: Frontiers in immunology

Published: May 15, 2024

TGF-β neutralization attenuates tumor residency of activated T cells to enhance systemic immunity in mice.

TGF-β neutralization attenuates tumor residency of activated T cells to enhance systemic immunity in mice.

Journal: iScience

Published: February 08, 2024

Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Journal: Research square

Published: October 04, 2023

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

Journal: Nature cancer

Published: August 10, 2023

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.

Journal: The Journal of clinical investigation

Published: June 01, 2023

Avelumab in Patients With Metastatic Colorectal Cancer.

Avelumab in Patients With Metastatic Colorectal Cancer.

Journal: The oncologist

Published: April 19, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026